323 related articles for article (PubMed ID: 3871770)
1. Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal BB; Kohr WJ; Hass PE; Moffat B; Spencer SA; Henzel WJ; Bringman TS; Nedwin GE; Goeddel DV; Harkins RN
J Biol Chem; 1985 Feb; 260(4):2345-54. PubMed ID: 3871770
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant human lymphotoxin (tumor necrosis factor-beta) produced by a mammalian cell line.
Hains JM; Aggarwal BB
Arch Biochem Biophys; 1989 Nov; 274(2):417-25. PubMed ID: 2802619
[TBL] [Abstract][Full Text] [Related]
3. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.
Aggarwal BB; Moffat B; Harkins RN
J Biol Chem; 1984 Jan; 259(1):686-91. PubMed ID: 6608523
[TBL] [Abstract][Full Text] [Related]
4. Purification of guinea pig tumor necrosis factor (TNF): comparison of its antiproliferative and differentiative activities for myeloid leukemic cell lines with those of recombinant human TNF.
Tamatani T; Kimura S; Hashimoto T; Onozaki K
J Biochem; 1989 Jan; 105(1):55-60. PubMed ID: 2786869
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
[TBL] [Abstract][Full Text] [Related]
6. Purification to electrophoretic homogeneity of human alpha lymphotoxin from a cloned continuous lymphoblastoid cell line IR 3.4.
Johnson DL; Yamamoto RS; Plunkett JM; Masunaka IK; Granger GA
Mol Immunol; 1983 Nov; 20(11):1241-4. PubMed ID: 6606757
[TBL] [Abstract][Full Text] [Related]
7. Purification of rabbit tumor necrosis factor.
Abe S; Gatanaga T; Yamazaki M; Soma G; Mizuno D
FEBS Lett; 1985 Jan; 180(2):203-6. PubMed ID: 3967764
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of human fibroblast derived differentiation inducing factor for human monoblastic leukemia cells identical to interleukin-6.
Noda M; Takeda K; Sugimoto H; Hosoi T; Takechi K; Hara T; Ishikawa H; Arimura H; Konno K
Anticancer Res; 1991; 11(2):961-8. PubMed ID: 1648338
[TBL] [Abstract][Full Text] [Related]
9. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells.
Loetscher H; Schlaeger EJ; Lahm HW; Pan YC; Lesslauer W; Brockhaus M
J Biol Chem; 1990 Nov; 265(33):20131-8. PubMed ID: 2173696
[TBL] [Abstract][Full Text] [Related]
10. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.
Clark-Lewis I; Kent SB; Schrader JW
J Biol Chem; 1984 Jun; 259(12):7488-94. PubMed ID: 6429132
[TBL] [Abstract][Full Text] [Related]
11. Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line.
Gascan H; Godard A; Ferenz C; Naulet J; Praloran V; Peyrat MA; Hewick R; Jacques Y; Moreau JF; Soulillou JP
J Biol Chem; 1989 Dec; 264(36):21509-15. PubMed ID: 2513320
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV
Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a T lymphocyte-derived differentiation-inducing factor for human promyelocytic cell line (HL-60) and its relationship to lymphotoxin.
Shimizu Y; Nakamura T; Niki T; Hemmi H; Sugamura K
Microbiol Immunol; 1989; 33(6):489-501. PubMed ID: 2788794
[TBL] [Abstract][Full Text] [Related]
14. An efficient method for the purification of tumor necrosis factor from rabbit serum.
Adams B; Regenass U; Cerletti N
Lymphokine Res; 1987; 6(3):203-14. PubMed ID: 3626624
[TBL] [Abstract][Full Text] [Related]
15. Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.
Green S; Dobrjansky A; Chiasson MA
J Natl Cancer Inst; 1982 Jun; 68(6):997-1003. PubMed ID: 6177893
[TBL] [Abstract][Full Text] [Related]
16. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.
Engelmann H; Aderka D; Rubinstein M; Rotman D; Wallach D
J Biol Chem; 1989 Jul; 264(20):11974-80. PubMed ID: 2545693
[TBL] [Abstract][Full Text] [Related]
17. Partial purification of murine B cell stimulatory factor (BSF)-1.
Ohara J; Lahet S; Inman J; Paul WE
J Immunol; 1985 Oct; 135(4):2518-23. PubMed ID: 3875657
[TBL] [Abstract][Full Text] [Related]
18. Studies on the purification of thrombopoietin from kidney cell culture medium.
McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD
J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244
[TBL] [Abstract][Full Text] [Related]
19. Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.
Ransom JH; Evans CH; McCabe RP; Pomato N; Heinbaugh JA; Chin M; Hanna MG
Cancer Res; 1985 Feb; 45(2):851-62. PubMed ID: 3881174
[TBL] [Abstract][Full Text] [Related]
20. Partial purification and characterization of phorbol ester-regulated translational inhibitor(s) in human HL-60 leukemic cells.
Konno S; Borelli TJ; Wu JM
J Biol Chem; 1986 Apr; 261(11):5010-7. PubMed ID: 3457011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
